SARS-CoV-2 variants and vulnerability at the global level

被引:85
作者
Chavda, Vivek P. [1 ]
Patel, Aayushi B. [2 ]
Vaghasiya, Darsh D. [2 ]
机构
[1] LM Coll Pharm, Dept Pharmaceut & Pharmaceut Technol, Ahmadabad 380009, Gujarat, India
[2] LM Coll Pharm, Pharm Sect, Ahmadabad, Gujarat, India
关键词
Delta plus variant; Delta variant; mutation; Omicron variant; SARS-CoV-2; vaccination; viral variant; OMICRON VARIANT; INFECTION; MUTATION; LINEAGE; GAMMA;
D O I
10.1002/jmv.27717
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Numerous variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic have evolved. Viral variants may evolve with harmful susceptibility to the immunity established with the existing COVID-19 vaccination. These variants are more transmissible, induce relatively extreme illness, have evasive immunological features, decrease neutralization using antibodies from vaccinated persons, and are more susceptible to re-infection. The Centers for Disease Control and Prevention (CDC) has categorized SARS-CoV-2 mutations as variants of interest (VOI), variants of concern (VOC), and variants of high consequence (VOHC). At the moment, four VOC and many variants of interest have been defined and require constant observation. This review article summarizes various variants of SARS-CoV-2 surfaced with special emphasis on VOCs that are spreading across the world, as well as several viral mutational impacts and how these modifications alter the properties of the virus.
引用
收藏
页码:2986 / 3005
页数:20
相关论文
共 153 条
  • [1] Aleem A, 2023, EMERGING VARIANTS SA
  • [2] SARS-CoV-2 Variants and Their Relevant Mutational Profiles: Update Summer 2021
    Alkhatib, Mohammad
    Svicher, Valentina
    Salpini, Romina
    Ambrosio, Francesca Alessandra
    Bellocchi, Maria Concetta
    Carioti, Luca
    Piermatteo, Lorenzo
    Scutari, Rossana
    Costa, Giosue
    Artese, Anna
    Alcaro, Stefano
    Shafer, Robert
    Ceccherini-Silberstein, Francesca
    [J]. MICROBIOLOGY SPECTRUM, 2021, 9 (03):
  • [3] Annavajhala M. K., 2021, B. 1.526, identified in New York. medRxiv, DOI [10.1101/2021.02.23.21252259(2021, DOI 10.1101/2021.02.23.21252259, 10.1101/2021.02.23.21252259]
  • [4] [Anonymous], 2019, How the flu virus can change: "drift" and "shift"
  • [5] New viral vaccines
    Arvin, AM
    Greenberg, HB
    [J]. VIROLOGY, 2006, 344 (01) : 240 - 249
  • [6] Basu, 2022, CURR RES PHARM DRUG, V3, DOI 10.1016/j.crphar.2022.100086
  • [7] Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
    Bernal, Jamie Lopez
    Andrews, Nick
    Gower, Charlotte
    Gallagher, Eileen
    Simmons, Ruth
    Thelwall, Simon
    Stowe, Julia
    Tessier, Elise
    Groves, Natalie
    Dabrera, Gavin
    Myers, Richard
    Campbell, Colin N. J.
    Amirthalingam, Gayatri
    Edmunds, Matt
    Zambon, Maria
    Brown, Kevin E.
    Hopkins, Susan
    Chand, Meera
    Ramsay, Mary
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07) : 585 - 594
  • [8] Bharat Biotech, 2021, COVAXIN INDIAS 1 IND, V154, P1
  • [9] Factor Influences for Diagnosis and Vaccination of Avian Infectious Bronchitis Virus (Gammacoronavirus) in Chickens
    Bhuiyan, Md Safiul Alam
    Amin, Zarina
    Abu Bakar, Ag Muhammad Sagaf
    Saallah, Suryani
    Yusuf, Noor Hydayaty Md
    Shaarani, Sharifudin Md
    Siddiquee, Shafiquzzaman
    [J]. VETERINARY SCIENCES, 2021, 8 (03)
  • [10] Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies
    Bian, Lianlian
    Gao, Fan
    Zhang, Jialu
    He, Qian
    Mao, Qunying
    Xu, Miao
    Liang, Zhenglun
    [J]. EXPERT REVIEW OF VACCINES, 2021, 20 (04) : 365 - 373